Multicenter, Double-Blind, Placebo-Controlled Study of Vonapanitase (PRT-201) Administered Immediately after Radiocephalic Arteriovenous Fistula Creation in Patients with Chronic Kidney Disease
This research study is enrolling patients with chronic kidney disease from Lake Washington Vascular who will undergo a Radiocephalic Arteriovenous Fistula creation to create a new access to their bloodstream for hemodialysis. This study is designed to assess the safety and effectiveness of an experimental drug called vonapanitase.
Krissa Gunderson, CRC: 425.732.5958, firstname.lastname@example.org
Irina Stipek, CRC: 425.732.5959, email@example.com
Clinical Trial Categories
Vascular / Surgical